LEADER 08210nam 22006133 450 001 9910794540303321 005 20231130003339.0 010 $a1-68108-808-8 035 $a(CKB)4100000011979688 035 $a(MiAaPQ)EBC6676570 035 $a(Au-PeEL)EBL6676570 035 $a(OCoLC)1260344220 035 $a(NjHacI)994100000011979688 035 $a(BIP)080871536 035 $a(PPN)270286845 035 $a(EXLCZ)994100000011979688 100 $a20210901d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCOVID-19 205 $a1st ed. 210 1$aSharjah :$cBentham Science Publishers,$d2021. 210 4$dİ2021. 215 $a1 online resource (223 pages) 311 $a1-68108-809-6 327 $aCover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE. 327 $aAsia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION. 327 $aLIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index. 330 $aProvides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings. This book is divided into two parts (I and II). Part I provides comprehensive information about 1 History of Coronaviruses, 2 Epidemiology of COVID-19, 3 Clinical presentation of this viral disease and 4 COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1 the prevention and treatment methodology, 2 mortality and long-term complications, 3 COVID-19 vaccines and future perspectives. Key Features: Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students. Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19. Six chapters in the first part which focus on clinical basics of COVID-19. Six chapters in the second part which cover broader topics for practical infection control. Multiple tables and figures which summarize and highlight important points. Presents a summary of the current standards for the evaluation and diagnosis of COVID-19. Features a detailed list of references, abbreviations, and symbols. This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVID19 diagnosis and management as part of their clinical training or professional work. 517 $aCOVID-19 606 $aCOVID-19 (Disease)$xPrevention 606 $aCOVID-19 (Disease)$xEconomic aspects 606 $aCOVID-19 (Disease)$xSocial aspects 606 $aCOVID-19 Pandemic, 2020- 610 $aCommunicable Diseases 610 $aMedical 615 0$aCOVID-19 (Disease)$xPrevention. 615 0$aCOVID-19 (Disease)$xEconomic aspects. 615 0$aCOVID-19 (Disease)$xSocial aspects. 615 0$aCOVID-19 Pandemic, 2020- 676 $a616.2414 700 $aMittal$b Neeraj$01485236 701 $aBhadada$b Sanjay K$01504090 701 $aKatare$b O. P$01485238 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910794540303321 996 $aCOVID-19$93732894 997 $aUNINA